Net Cash Provided by (Used in) Financing Activities in USD of PUMA BIOTECHNOLOGY, INC. from Q4 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Puma Biotechnology, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q4 2010 to Q1 2025.
  • Puma Biotechnology, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was -$11.3M.
  • Puma Biotechnology, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was -$33.8M.
  • Puma Biotechnology, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $0.000, a 100% decline from 2022.
  • Puma Biotechnology, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $12.2M.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

PUMA BIOTECHNOLOGY, INC. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 -$11.3M -$11.3M Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-08
Q1 2024 $0 $0 Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-08
Q1 2023 $0 -$9.85M -100% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q1 2022 $9.85M +$9.85M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q1 2021 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q1 2019 $1.08M -$2.07M -65.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q1 2018 $3.15M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q1 2011 $3.94K* Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q4 2010 $7K* Sep 16, 2010 Dec 31, 2010 10-K 2013-04-01

PUMA BIOTECHNOLOGY, INC. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$33.8M -$33.8M Jan 1, 2024 Dec 31, 2024 10-K 2025-02-27
2023 $0 -$12.2M -100% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-27
2022 $12.2M +$44.2M Jan 1, 2022 Dec 31, 2022 10-K 2025-02-27
2021 -$31.9M -$22M -221% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 -$9.93M +$57.1M +85.2% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-02
2019 -$67.1M -$176M -162% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-03
2018 $108M +$33.3M +44.4% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 $75.1M -$87.3M -53.8% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-28
2016 $162M Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
2013 $2.22M -$127M -98.3% Jan 1, 2013 Dec 31, 2013 10-K 2014-03-03
2012 $129M +$72.3M +127% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-03
2011 $57M Jan 1, 2011 Dec 31, 2011 10-K 2014-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.